当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 资产负债表

海尔生物

(688139)

  

流通市值:105.96亿  总市值:105.96亿
流通股本:3.16亿   总股本:3.16亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金973,449,794.97843,825,249.51691,844,623.72654,325,470.06
  交易性金融资产505,408,853.88447,591,068.5653,414,470.32792,041,914.78
  衍生金融资产178,944.33---
  应收票据及应收账款512,325,267.13411,714,556.83439,846,071.91423,793,436.72
  其中:应收票据6,883,837.477,292,980.638,857,425.9619,032,258.57
        应收账款505,441,429.66404,421,576.2430,988,645.95404,761,178.15
  应收款项融资12,881,171.1919,702,632.5713,366,860.0512,193,257.63
  预付款项28,026,403.8330,087,423.0433,162,032.341,668,946.26
  其他应收款合计8,018,789.888,050,329.97,688,434.947,719,453.49
  存货337,105,155.33345,474,341.6316,654,053.99303,027,739.69
  合同资产13,707,92513,866,048.188,107,246.268,101,904.35
  一年内到期的非流动资产339,776,836.79525,514,411.75373,680,826.88353,317,848.03
  其他流动资产10,510,796.9813,015,696.8912,313,030.6110,904,508.97
  流动资产合计2,741,389,939.312,658,841,758.772,550,077,650.982,607,094,479.98
非流动资产:
  长期股权投资189,056,364.98188,228,569.38187,238,645.78185,774,018.6
  其他权益工具投资52,108,10052,108,10040,206,222.5440,206,222.54
  其他非流动金融资产17,807,329.1217,807,329.1218,000,00018,000,000
  投资性房地产7,896,857.218,089,018.478,281,179.728,473,340.97
  固定资产865,612,064.66858,715,732.42862,519,384.29781,279,972.13
  在建工程65,144,555.4854,968,724.457,539,589.63115,345,386.15
  使用权资产8,085,566.659,325,392.4810,064,262.4610,554,612.46
  无形资产349,904,645.93360,497,939.89369,914,583.78382,234,442.22
  商誉757,847,032.69758,242,562.84758,387,976.51758,734,827.93
  长期待摊费用5,083,752.675,602,653.426,149,601.535,901,732.97
  递延所得税资产94,016,181.2989,674,622.783,165,709.9776,207,932.81
  其他非流动资产701,754,897.67729,412,485.34698,899,615.25622,272,642.98
  非流动资产合计3,114,317,348.353,132,673,130.463,100,366,771.463,004,985,131.76
  资产总计5,855,707,287.665,791,514,889.235,650,444,422.445,612,079,611.74
流动负债:
  短期借款10,003,561.6410,007,123.2810,006,50010,005,055.56
  应付票据及应付账款460,004,224.55429,382,999.1415,356,450.33405,738,043.59
  其中:应付票据107,148,559.1694,913,195.96105,592,011.84120,188,305.31
        应付账款352,855,665.39334,469,803.14309,764,438.49285,549,738.28
  合同负债122,882,725.05170,918,330.5692,609,220.5588,353,110.09
  应付职工薪酬63,367,987.6182,614,116.7975,423,297.7470,694,265.57
  应交税费24,489,125.3744,425,054.4448,592,059.6947,808,653.79
  其他应付款合计290,979,411.86251,145,571.81255,233,126.45255,084,363.87
  一年内到期的非流动负债80,490,014.1180,595,123.421,799,306.4212,032,864.59
  其他流动负债16,270,553.516,401,943.917,272,677.147,560,086.38
  流动负债合计1,068,487,603.691,085,490,263.29926,292,638.32897,276,443.44
非流动负债:
  长期借款---10,006,500
  租赁负债4,637,322.834,544,680.176,737,003.086,092,033.39
  长期应付款--57,283,117.6456,606,273.48
  预计负债6,308,817.646,308,817.646,497,810.7812,969,721.33
  递延收益29,951,795.2926,084,497.2220,721,062.0721,536,973.23
  递延所得税负债44,247,209.9745,891,814.8147,536,844.0249,221,135.1
  非流动负债合计85,145,145.7382,829,809.84138,775,837.59156,432,636.53
  负债合计1,153,632,749.421,168,320,073.131,065,068,475.911,053,709,079.97
所有者权益(或股东权益):
  实收资本(或股本)316,492,922317,952,508317,952,508317,952,508
  资本公积1,878,115,033.261,976,397,633.341,981,720,560.131,980,027,786.85
  减:库存股150,041,011.44248,682,662.57231,888,823.98202,512,658.31
  其他综合收益7,446,240.857,455,309.09-2,395,903.04-2,068,108.49
  盈余公积158,976,254158,976,254158,976,254158,976,254
  未分配利润2,243,058,864.422,163,598,018.232,111,258,117.992,055,606,402.43
  归属于母公司股东权益合计4,454,048,303.094,375,697,060.094,335,622,713.14,307,982,184.48
  少数股东权益248,026,235.15247,497,756.01249,753,233.43250,388,347.29
  股东权益合计4,702,074,538.244,623,194,816.14,585,375,946.534,558,370,531.77
  负债和股东权益合计5,855,707,287.665,791,514,889.235,650,444,422.445,612,079,611.74
公告日期2026-04-302026-03-282025-10-312025-08-27
审计意见(境内)标准无保留意见
TOP↑